About half of the corona patients who end up in hospital experience complications. For example, they are affected by kidney or liver problems, additional lung problems, anemia or cardiac arrhythmias. A major British investigation into this has been released today.
–
–
Door Metronieuws.nl
–
Of the patients in the group studied who survived their corona infection, almost 45 percent had developed such complications. Researchers in the scientific journal The Lancet calculate this.
73,000 corona patients examined
The researchers analyzed data from more than 73,000 corona patients who have been in British hospitals with Covid-19. Of these patients, 28 percent died within a month. Complications were more common in patients who did not survive their disease. However, a large proportion of patients who left the hospital alive also suffered from other health problems. Those problems came on top of the lung infection caused by the coronavirus.
Complications are more common in the elderly, but also in a significant proportion of younger patients. In the group aged 19 to 29, 27 percent experienced additional problems. This was the case in 37 percent of patients aged 30 to 39 years. The researchers: “Although patients under the age of 50 have a low risk of dying from Covid-19, we found high complication rates in all age groups.”
Many patients already had a condition
Eight out of ten patients already suffered from another condition before hospitalization. People with cardiovascular and chronic lung diseases most often ended up in hospital because of corona.
One of the questions is how long additional health problems last. By identifying short-term problems, the researchers also hope to contribute to a better understanding. Understanding the long-term pressure the coronavirus pandemic will put on health systems. “And to those who survive Covid-19.”
The Lancet has been a British medical journal since the year 1823. It is considered by many medical scientists to be one of the most renowned scientific journals. This in addition to Nature, Science and the New England Journal of Medicine.
